Fallbericht
Surgery for Locally Advanced Stage IIIB (T4N2) EGFR-Mutated Lung Adenocarcinoma in the Era of Targeted Therapy: A Case Report
Malignancy Spectrum · 2026 · 3 (2) · 82
DOI: 10.15302/msp.2026.0014 ↗Kurz gefasst
Fallbericht in der Zeitschrift Malignancy Spectrum, 2026. Verfasst von Sergew Yeskov und 2 weiteren Autor:innen. Die Arbeit nennt 5 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Yeskov, S., Krasny, S., & Sukolinskaya, A. (2026). Surgery for Locally Advanced Stage IIIB (T4N2) EGFR-Mutated Lung Adenocarcinoma in the Era of Targeted Therapy: A Case Report. Malignancy Spectrum, 3(2), 82. https://doi.org/10.15302/msp.2026.0014
Vancouver
Yeskov S, Krasny S, Sukolinskaya A. Surgery for Locally Advanced Stage IIIB (T4N2) EGFR-Mutated Lung Adenocarcinoma in the Era of Targeted Therapy: A Case Report. Malignancy Spectrum. 2026;3(2):82. doi:10.15302/msp.2026.0014
BibTeX
@article{Yeskov2026,
author = {Yeskov, Sergew and Krasny, Sergei and Sukolinskaya, Alena},
title = {Surgery for Locally Advanced Stage IIIB (T4N2) EGFR-Mutated Lung Adenocarcinoma in the Era of Targeted Therapy: A Case Report},
journal = {Malignancy Spectrum},
year = {2026},
volume = {3},
number = {2},
pages = {82},
doi = {10.15302/msp.2026.0014}
}
EUVIMED